Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
CLOSTRIDIUM PERFRINGENS TYP B CLOSTRIDIUM PERFRINGENS TYPE C TOXOID CLOSTRIDIUM PERFRINGENS TYPE D TOXOID CLOSTRIDIUM HAEMOLYTICUM ANACULTURE CLOSTRIDIUM CHAUVOEI WHOLE CULTURE CLOSTRIDIUM NOVYI ANACULTURE CLOSTRIDIUM SEPTICUM TOXOID CLOSTRIDIUM TETANI TOXOID
Pfizer Healthcare Ireland
QI02AB01
Suspension for Injection
Immunological - Inactivated vaccine
Bovine
2009-05-29
IRISH MEDICINES BOARD ACT 1995, AS AMENDED EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 VPA: 10019/115/001 Case No: 7008322 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: PFIZER HEALTHCARE IRELAND TRADING AS: PFIZER ANIMAL HEALTH, RINGASKIDDY, CO. CORK, IRELAND an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: COVEXIN 8 SUSPENSION FOR INJECTION FOR SHEEP AND CATTLE The particulars of which are set out in the attached Schedule. The authorisation is also subject to any special conditions as may be specified in the Schedule. The authorisation,unless revoked, shall continue in force from 13/01/2010. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 21/08/2010_ _CRN 7008322_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Covexin 8 Suspension for injection for sheep and cattle. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION * ELISA According to Ph.Eur. ** Challenge test according to Ph.Eur. # In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Suspension for injection. Light brown aqueous suspension that settles on storage. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep from 2 weeks of Soma hati kamili